Literature DB >> 17277934

Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol.

Dawn M Eagle1, Miles R A Tufft, Hannah L Goodchild, Trevor W Robbins.   

Abstract

RATIONALE: The stop-signal reaction time (SSRT) task measures inhibition of a response that has already been initiated, i.e. the ability to stop. 'Impulsive' human subjects, e.g. with attention deficit and hyperactivity disorder (ADHD), have longer SSRTs. Both SSRT and go-trial reaction time (GoRT) may be sensitive to drugs such as d-amphetamine, methylphenidate and modafinil, both in normal subjects and those with ADHD.
OBJECTIVES: To investigate the effects of modafinil (3, 10, 30 and 100 mg/kg) and methylphenidate (0.3, 1.0 and 3.0 mg/kg) on SSRT task performance in the rat. To investigate the possible contribution of dopamine receptors in the action of these drugs using the mixed D1/D2 dopamine receptor antagonist cis-flupenthixol.
RESULTS: Modafinil significantly decreased SSRT with little effect on GoRT but only in rats with slow baseline SSRTs. Fast SSRTs were not changed by modafinil. Methylphenidate decreased GoRTs of all rats. However, methylphenidate had baseline-dependent effects on SSRT, decreasing SSRT in slow responders but increasing SSRT in fast responders. Cis-flupenthixol (0.01, 0.04 and 0.125 mg/kg) had no effects on SSRT but increased GoRT at higher doses. At the lowest dose (0.01 mg/kg), cis-flupenthixol failed to disrupt the SSRT-decreasing effects of either modafinil or methylphenidate, whereas at 0.04 mg/kg, the cis-flupenthixol-dependent increase in GoRT was antagonised by methylphenidate but not by modafinil.
CONCLUSIONS: This evidence supports a hypothesis that stop and go processes are under control of distinct neurochemical mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277934     DOI: 10.1007/s00213-007-0701-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  57 in total

1.  Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD?

Authors:  A Marije Boonstra; J J Sandra Kooij; Jaap Oosterlaan; Joseph A Sergeant; Jan K Buitelaar
Journal:  J Clin Exp Neuropsychol       Date:  2005-04       Impact factor: 2.475

2.  Cognitive enhancing effects of modafinil in healthy volunteers.

Authors:  Danielle C Turner; Trevor W Robbins; Luke Clark; Adam R Aron; Jonathan Dowson; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2002-11-01       Impact factor: 4.530

3.  Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat.

Authors:  Kerry A Waters; Katherine E Burnham; Desmond O'connor; Gerard R Dawson; Rebecca Dias
Journal:  J Psychopharmacol       Date:  2005-03       Impact factor: 4.153

4.  Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder.

Authors:  Marijn Lijffijt; J Leon Kenemans; Annemiek ter Wal; Elise H Quik; C Kemner; Herman Westenberg; Marinus N Verbaten; Herman van Engeland
Journal:  Eur Psychiatry       Date:  2005-07-01       Impact factor: 5.361

5.  Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.

Authors:  J K Buitelaar; R J Van der Gaag; H Swaab-Barneveld; M Kuiper
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-08       Impact factor: 8.829

6.  Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats.

Authors:  Tyler W Feola; Harriet de Wit; Jerry B Richards
Journal:  Behav Neurosci       Date:  2000-08       Impact factor: 1.912

Review 7.  The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

8.  Attention deficit disorder with hyperactivity: differential effects of methylphenidate on impulsivity.

Authors:  M D Rapport; G J DuPaul; G Stoner; B K Birmingham; G Masse
Journal:  Pediatrics       Date:  1985-12       Impact factor: 7.124

9.  Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

Authors:  J S Lin; B Roussel; H Akaoka; P Fort; G Debilly; M Jouvet
Journal:  Brain Res       Date:  1992-09-25       Impact factor: 3.252

10.  Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.

Authors:  Amy Ft Arnsten; Anne G Dudley
Journal:  Behav Brain Funct       Date:  2005-04-22       Impact factor: 3.759

View more
  92 in total

1.  Stress and alcohol cues exert conjoint effects on go and stop signal responding in male problem drinkers.

Authors:  Martin Zack; Tracy M Woodford; Anne M Tremblay; Lindsay Steinberg; Laurie A Zawertailo; Usoa E Busto
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Clinical and neurocognitive changes with modafinil in obsessive-compulsive disorder: a case report.

Authors:  Winand H Dittrich; Thomas Johansen; Ashwini K Padhi; Ian E Smith; Samuel R Chamberlain; Naomi A Fineberg
Journal:  Psychopharmacology (Berl)       Date:  2010-08-06       Impact factor: 4.530

3.  Methylphenidate has nonlinear dose effects on cued response inhibition in adults but not adolescents.

Authors:  Nicholas W Simon; Bita Moghaddam
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

4.  Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.

Authors:  Chelsea L Robertson; Kenji Ishibashi; Mark A Mandelkern; Amira K Brown; Dara G Ghahremani; Fred Sabb; Robert Bilder; Tyrone Cannon; Jacqueline Borg; Edythe D London
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

5.  Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization.

Authors:  Travis M Moschak; Katherine A Stang; Tamara J Phillips; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2012-02-04       Impact factor: 4.530

Review 6.  Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition.

Authors:  Adam R Aron; Sarah Durston; Dawn M Eagle; Gordon D Logan; Cathy M Stinear; Veit Stuphorn
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

Review 7.  The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks.

Authors:  Dawn M Eagle; Andrea Bari; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

Review 8.  CNTRICS final task selection: executive control.

Authors:  Deanna M Barch; Todd S Braver; Cameron S Carter; Russell A Poldrack; Trevor W Robbins
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

9.  Response inhibition and response monitoring in a saccadic double-step task in schizophrenia.

Authors:  Katharine N Thakkar; Jeffrey D Schall; Gordon D Logan; Sohee Park
Journal:  Brain Cogn       Date:  2015-03-10       Impact factor: 2.310

10.  Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.

Authors:  Ajna Hamidovic; Andrea Dlugos; Andrew Skol; Abraham A Palmer; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.